Published: Vol 4, Iss 10, May 20, 2014 DOI: 10.21769/BioProtoc.1124 Views: 14570
Reviewed by: Sabine Le SauxAnonymous reviewer(s)
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
RNA Chromatin Immunoprecipitation (RNA-ChIP) in Caenorhabditis elegans
Germano Cecere and Alla Grishok
Dec 20, 2014 14655 Views
Chromatin Immunoprecipitation (ChIP) Assay for Detecting Direct and Indirect Protein – DNA Interactions in Magnaporthe oryzae
Gang Li [...] Richard A. Wilson
Nov 5, 2015 14893 Views
Abstract
Elucidation of molecular mechanisms of genome functions requires identification of molecules interacting with genomic regions of interest in vivo. To this end, it is useful to isolate the target regions retaining molecular interactions. We established locus-specific chromatin immunoprecipitation (ChIP) technologies consisting of insertional ChIP (iChIP) and engineered DNA-binding molecule-mediated ChIP (enChIP) for isolation of target genomic regions (Hoshino and Fujii, 2009; Fujita and Fujii, 2011; Fujita and Fujii, 2012; Fujita and Fujii, 2013a; Fujita and Fujii, 2013b; Fujita et al., 2013). Identification and characterization of molecules interacting with the isolated genomic regions facilitates understanding of molecular mechanisms of functions of the target genome regions.
Here, we describe enChIP, in which engineered DNA-binding molecules, such as zinc-finger proteins, transcription activator-like (TAL) proteins, and a catalytically inactive Cas9 (dCas9) plus small guide RNA (gRNA), are utilized for affinity purification of target genomic regions. The scheme of enChIP is as follows:
1. A zinc-finger protein, TAL or dCas9 plus gRNA is generated to recognize DNA sequence in a genomic region of interest.
2. The engineered DNA-binding molecule is fused with a tag(s) and the nuclear localization signal (NLS), and expressed in the cell to be analyzed.
3. The resultant cell is crosslinked, if necessary, and lysed, and DNA is fragmented.
4. The complexes including the engineered DNA-binding molecule are subjected to affinity purification such as mmunoprecipitation. The isolated complexes retain molecules interacting with the genomic region of interest.
5. Reverse crosslinking and subsequent purification of DNA, RNA, or proteins allow identification and characterization of these molecules.
In this protocol, we describe enChIP with a TAL protein to isolate a genomic region of interest and analyze the interacting proteins by mass spectrometry (Fujita et al., 2013).
Materials and Reagents
Equipment
Procedure
Recipes
Glycine (MW: 75.07) | 18.8 g |
H2O | to 200 ml |
Deoxycholic acid sodium salt monohydrate | 1 g |
H2O | to 10 ml |
1 M Tris (pH 8.0) | 400 µl |
0.5 M EDTA | 80 µl |
IGEPAL CA-630 | 200 µl |
Complete, mini, EDTA-free | 4 tablets |
Double distilled water (DDW) | 39.32 ml |
1 M Tris (pH 8.0) | 400 µl |
0.5 M EDTA | 80 µl |
5 M NaCl | 4 ml |
Triton X-100 | 400 µl |
10% sodium deoxycholate | 2 ml |
30% lauroylsarcosine | 666 µl |
Complete, mini, EDTA-free | 4 tablets |
DDW | 32.46 ml |
1 M Tris (pH 8.0) | 100 µl |
0.5 M EDTA | 20 µl |
0.1 M EGTA | 50 µl |
5 M NaCl | 300 µl |
10% sodium deoxycholate | 100 µl |
10% SDS | 100 µl |
Complete, mini, EDTA-free | 1 tablet |
DDW | 9.33 ml |
Tween-20 | 1 ml |
DDW | 9 ml |
PBS | 10 ml |
10% Tween-20 | 10 µl |
PBS | 10 ml |
10% Tween-20 | 10 µl |
7.5% BSA fraction V | 133 µl |
MLB3 | 4.75 ml |
Triton X-100 | 250 µl |
1 M Tris (pH 8.0) | 200 µl |
0.5 M EDTA | 40 µl |
5 M NaCl | 300 µl |
Triton X-100 | 100 µl |
10% SDS | 100 µl |
DDW | 9.26 ml |
1 M Tris (pH 8.0) | 200 µl |
0.5 M EDTA | 40 µl |
5 M NaCl | 1 ml |
Triton X-100 | 100 µl |
10% SDS | 100 µl |
DDW | 8.56 ml |
1 M Tris (pH 8.0) | 200 µl |
0.5 M EDTA | 40 µl |
8 M LiCl | 625 µl |
IGEPAL CA-630 | 100 µl |
10% sodium deoxycholate | 1 ml |
DDW | 18.035 ml |
1 M Tris (pH 7.5) | 500 µl |
5 M NaCl | 300 µl |
IGEPAL CA-630 | 10 µl |
DDW | 9.19 ml |
5 mg/ml 3x FLAG peptide in TBS | 50 µl |
TBS-IGEPAL CA-630 | 450 µl |
1 M Tris-HCl (pH 6.8) | 6.25 ml |
2-mercaptoethanol | 5 ml |
SDS | 2 g |
Sucrose | 5 g |
Bromophenol blue | 2 mg |
DDW | to 50 ml |
Acknowledgments
This protocol was adapted from the previously published paper (Fujita et al., 2013). We thank F. Kitaura for technical assistance. This work was supported by Research Institute for Microbial Diseases (T.F. and H.F.), Program for Combined Research Fields from Immunology Frontier Research Center, Osaka University (H.F.), the Takeda Science Foundation (H.F. and T.F.), the Asahi Glass Foundation (H.F.), A-STEP from Japan Science and Technology Agency (H.F.), Grant-in-Aid for Young Scientists (B) (#22710185) (T.F.), Grant-in-Aid for Scientific Research on Innovative Areas ‘‘Cell Fate’’ (#23118516) (T.F.), ‘‘The Genofield’’ (#23114707) (H.F.), ‘‘Transcription Cycle’’ (25118512) (H.F.).
References
Article Information
Copyright
© 2014 The Authors; exclusive licensee Bio-protocol LLC.
How to cite
Fujita, T. and Fujii, H. (2014). Identification of Proteins Interacting with Genomic Regions of Interest in vivo Using Engineered DNA-binding Molecule-mediated Chromatin Immunoprecipitation (enChIP). Bio-protocol 4(10): e1124. DOI: 10.21769/BioProtoc.1124.
Category
Molecular Biology > DNA > DNA-protein interaction
Biochemistry > Protein > Immunodetection
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link